# OptimizeRx Corp (OPRX) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from OptimizeRx Corp's 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/OPRX/mda/fy2025/): filed 2026-03-12; accession 0001448431-26-000005 (https://www.sec.gov/Archives/edgar/data/1448431/000144843126000005/oprx-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/OPRX/mda/fy2024/): filed 2025-03-20; accession 0001213900-25-025576 (https://www.sec.gov/Archives/edgar/data/1448431/000121390025025576/ea0234670-10k_optimize.htm)
- [FY 2023 MD&A](/company/OPRX/mda/fy2023/): filed 2024-04-15; accession 0001213900-24-033000 (https://www.sec.gov/Archives/edgar/data/1448431/000121390024033000/ea0203848-10k_optimizerx.htm)
- [FY 2022 MD&A](/company/OPRX/mda/fy2022/): filed 2023-03-10; accession 0001213900-23-019233 (https://www.sec.gov/Archives/edgar/data/1448431/000121390023019233/f10k2022_optimizerx.htm)
- [FY 2021 MD&A](/company/OPRX/mda/fy2021/): filed 2022-02-28; accession 0001213900-22-009736 (https://www.sec.gov/Archives/edgar/data/1448431/000121390022009736/f10k2021_optimizerxcorp.htm)

Back to /company/OPRX/